Clinical Trial Update: Observational Study of Apremilast in Patients With Psoriasis in The Netherlands

View source ↗

Summary

An observational study of Apremilast in patients with psoriasis in the Netherlands has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Status: COMPLETED